BioSpace News Archive

MEDIROM Healthcare Technologies Inc., a holistic healthcare company from Japan, announced that it has completed the sale of an additional 60,000 ADSs at the public offering price of US$15.00 per ADS, pursuant to the exercise by the underwriter of the over-allotment option granted to it in connection with the Company’s initial public offering.

Clover plans to initiate a global phase 2/3 trial in the first half of 2021 with an interim analysis for vaccine efficacy potentially in the middle of 2021

The Coalition for Epidemic Preparedness Innovations (CEPI) continues to support Clover’s COVID-19 vaccine candidate and will fund its development through licensure.

Evotec announced that Dr Cord Dohrmann has been appointed to the German Council of Science and Humanities for a term of three years.

Collaboration combines Sosei Heptares’ leading structure-based drug design platform with Metrion Biosciences’ ion channel expertise

Published Studies Explore How a Variant of p53 Contributes to the Development of Alzheimer’s Disease (AD) and How Plasma Levels of this Variant Can Serve as a Prognostic Biomarker Predicting Progression to AD Early in the Disease Process

Takeda Pharmaceutical Company Limited announced that it has completed the previously announced sale of TachoSil® Fibrin Sealant Patch to Corza Health, Inc. for €350 million.

Suzhou Basecare Medical Co., Ltd. — set to list on the Hong Kong Stock Exchange on February 8th, 2021— is the newest unicorn in the field of assisted reproduction.

Orexo AB, has mandated ABG Sundal Collier AB to arrange a series of fixed income investor meetings in the Nordics, commencing on 1 February 2021.

Vicore Pharma Holding AB, a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders, published data from the phase II study ATTRACT online and submitted it to a peer reviewed journal.